Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

St. Jude Children's Research Hospital

Single-cell transcriptomic analysis of B-ALL: leukemia cell state and genetic alterations 3:59
Single-cell transcriptomic analysis of B-ALL: leukemia cell state and genetic alterations
Ilaria Iacobucci • 11 Dec 2023
Acute leukemias of ambiguous lineage: challenges and approaches 2:28
Acute leukemias of ambiguous lineage: challenges and approaches
Ilaria Iacobucci • 7 Sep 2023
Challenges in diagnosing and treating Ph-like ALL 2:15
Challenges in diagnosing and treating Ph-like ALL
Ilaria Iacobucci • 7 Sep 2023
Current and emerging treatment options for Ph-like ALL 1:50
Current and emerging treatment options for Ph-like ALL
Ilaria Iacobucci • 7 Sep 2023
Preliminary results from Phase I study of CD123 CAR-T therapy in pediatric R/R AML 3:41
Preliminary results from Phase I study of CD123 CAR-T therapy in pediatric R/R AML
Swati Naik • 20 Feb 2023
Impact of cytogenetic abnormalities on OS following SCT in pediatric AML 1:45
Impact of cytogenetic abnormalities on OS following SCT in pediatric AML
Akshay Sharma • 12 Dec 2022
Phase II study of MGTA-145 in combination with plerixafor for HSC mobilization in patients with SCD 1:44
Phase II study of MGTA-145 in combination with plerixafor for HSC mobilization in patients with SCD
Akshay Sharma • 12 Dec 2022
Treatment of severe SCD with OTQ923 CRISPR/Cas9 gene therapy 0:56
Treatment of severe SCD with OTQ923 CRISPR/Cas9 gene therapy
Akshay Sharma • 12 Dec 2022
A machine learning model to improve outcome prediction following allogeneic transplantation 2:43
A machine learning model to improve outcome prediction following allogeneic transplantation
Akshay Sharma • 12 Dec 2022
The impact of IKZF1 alterations on clinical outcomes of patients in the Total Therapy XV/XVI studies 0:59
The impact of IKZF1 alterations on clinical outcomes of patients in the Total Therapy XV/XVI studies
Ruth Wang'ondu • 11 Dec 2022
The role of Ikaros alterations in B-ALL 0:59
The role of Ikaros alterations in B-ALL
Ruth Wang'ondu • 11 Dec 2022
The importance of promoting minorities in hematology 0:44
The importance of promoting minorities in hematology
Ruth Wang'ondu • 11 Dec 2022
Novel targeted antibodies for R/R B-ALL 0:47
Novel targeted antibodies for R/R B-ALL
Yaqi Zhao • 11 Apr 2022
Genomic determinants of response to blinatumomab 1:37
Genomic determinants of response to blinatumomab
Yaqi Zhao • 11 Apr 2022
Update on the INO-VATE trial: inotuzumab vs chemotherapy for ALL 1:59
Update on the INO-VATE trial: inotuzumab vs chemotherapy for ALL
Yaqi Zhao • 11 Apr 2022
UBTF tandem duplications identified as a subtype-defining lesion in pediatric AML 4:32
UBTF tandem duplications identified as a subtype-defining lesion in pediatric AML
Masayuki Umeda • 1 Dec 2021
The content of VJHemOnc is intended for healthcare professionals